The Czech branch of the American company Novavax is close to launching the production of a coronavirus vaccine. Mladá fronta Dnes writes that the vaccine with almost 90% efficiency could be available in April 2021. In total, the American group Novavax wants to produce up to 1 billion doses by the end of the year, in which its Czech subsidiary is to participate.
Source: CIA News
Prepared by the team of foreign office CzechTrade Chicago